Tolerance without clonal expansion: Self-antigen-expressing B cells program self-reactive T cells for future deletion

Journal of Immunology

Volumn 181, Issue 8, 2008, Pages 5748-5759

  Frommer, Friederike ^a   Heinen, Tobias J A J ^b   Wunderlich, F Thomas ^b   Yogev, Nir ^a   Buch, Thorsten ^c   Roers, Axel ^b   Bettelli, Estelle ^d   Müller, Werner ^e   Anderton, Stephen M ^f   Waisman, Ari ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; AUTOANTIGEN; CD5 PROTEIN, MOUSE; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PD 1 ANTIGEN, MOUSE; PD-1 ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD25+ T LYMPHOCYTE; CELL DEATH; CELL INTERACTION; CONTROLLED STUDY; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD5; ANTIGENS, DIFFERENTIATION; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; CELL PROLIFERATION; CLONAL DELETION; GENE EXPRESSION REGULATION; HOMEOSTASIS; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 54049107281     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.8.5748     Document Type: Article

References (47)

1. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258: 1156-1159.
2. Eynon, E. E., and D. C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175: 131-138.
3. Eynon, E. E., and D. C. Parker. 1993. Parameters of tolerance induction by antigen targeted to B lymphocytes. J. Immunol. 151: 2958-2964. (Pubitemid 23282608)
4. Day, M. J., A. G. Tse, M. Puklavec, S. J. Simmonds, and D. W. Mason. 1992. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats. J. Exp. Med. 175: 655-659.
5. Saoudi, A., S. Simmonds, I. Huitinga, and D. Mason. 1995. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J. Exp. Med. 182: 335-344.
6. Chen, C., A. Rivera, N. Ron, J. P. Dougherty, and Y. Ron. 2001. A gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood 97: 886-894. (Pubitemid 32154270)
7. Melo, M. E., J. Qian, M. El-Amine, R. K. Agarwal, N. Soukhareva, Y. Kang, and D. W. Scott. 2002. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J. Immunol. 168: 4788-4795.
8. Xu, B., and D. W. Scott. 2004. A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP. Clin. Immunol. 111: 47-52. (Pubitemid 38482081)
9. Chen, C. C., A. Rivera, J. P. Dougherty, and Y. Ron. 2004. Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen. Blood 103: 4616-4618.
10. Litzinger, M. T., Y. Su, T. C. Lei, N. Soukhareva, and D. W. Scott. 2005. Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction. J. Immunol. 175: 780-787.
11. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21: 70-71. (Pubitemid 29036285)
12. Lakso, M., B. Sauer, B. Mosinger, Jr., E. J. Lee, R. W. Manning, S. H. Yu, K. L. Mulder, and H. Westphal. 1992. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89: 6232-6236.
13. Koch, N., W. Lauer, J. Habicht, and B. Dobberstein. 1987. Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii): an alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J. 6: 1677-1683.
14. Kontgen, F., G. Suss, C. Stewart, M. Steinmetz, and H. Bluethmann. 1993. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 5: 957-964. (Pubitemid 23241767)
15. Pham-Dinh, D., M. G. Mattei, J. L. Nussbaum, G. Roussel, P. Pontarotti, N. Roeckel, I. H. Mather, K. Artzt, K. F. Lindahl, and A. Dautigny. 1993. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 90: 7990-7994. (Pubitemid 23260840)
16. Mao, X., Y. Fujiwara, and S. H. Orkin. 1999. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. USA 96: 5037-5042. (Pubitemid 29214531)
17. Zambrowicz, B. P., A. Imamoto, S. Fiering, L. A. Herzenberg, W. G. Kerr, and P. Soriano. 1997. Disruption of overlapping transcripts in the ROSA β geo 26 gene trap strain leads to widespread expression of β-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. USA 94: 3789-3794.
18. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081. (Pubitemid 36570063)
19. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352-355
20. Rickert, R. C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25: 1317-1318.
21. Rolink, A., and F. Melchers. 1996. B-cell development in the mouse. Immunol. Lett. 54: 157-161.
22. Hovelmeyer, N., Z. Hao, K. Kranidioti, G. Kassiotis, T. Buch, F. Frommer, L. von Hoch, D. Kramer, L. Minichiello, G. Kollias, et al. 2005. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 175: 5875-5884. (Pubitemid 41508072)
23. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405-413. (Pubitemid 2134466)
24. Rolink, A., F. Melchers, and J. Andersson. 1996. The SCID but not the RAG-2 gene product is required for S μ-S ε heavy chain class switching. Immunity 5: 319-330. (Pubitemid 26366755)
25. Becher, B., B. G. Durell, A. V. Miga, W. F. Hickey, and R. J. Noelle. 2001. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193: 967-974. (Pubitemid 32525869)
26. Buch, T., F. L. Heppner, C. Tertilt, T. J. Heinen, M. Kremer, F. T. Wunderlich, S. Jung, and A. Waisman. 2005. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2: 419-426. (Pubitemid 40916560)
27. Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23: 5080-5081. (Pubitemid 26012492)
28. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1219-1227. (Pubitemid 43045633)
29. Reichardt, P., B. Dornbach, S. Rong, S. Beissert, F. Gueler, K. Loser, and M. Gunzer. 2007. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 110: 1519-1529. (Pubitemid 47443968)
30. + regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
31. Ernst, B., D. S. Lee, J. M. Chang, J. Sprent, and C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11: 173-181. (Pubitemid 29428810)
32. Stockinger, B., G. Kassiotis, and C. Bourgeois. 2004. Homeostasis and T cell regulation. Curr. Opin. Immunol. 16: 775-779.
33. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950. (Pubitemid 35154008)
34. Roers, A., L. Siewe, E. Strittmatter, M. Deckert, D. Schluter, W. Stenzel, A. D. Gruber, T. Krieg, K. Rajewsky, and W. Muller. 2004. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200: 1289-1297. (Pubitemid 39552570)
35. + T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6: 280-286.
36. Kataoka, T. 2005. The caspase-8 modulator c-FLIP. Crit. Rev. Immunol. 25: 31-58.
37. Gross, A., J. Jockel, M. C. Wei, and S. J. Korsmeyer. 1998. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17: 3878-3885. (Pubitemid 28333974)
38. Hawiger, D., R. F. Masilamani, E. Bettelli, V. K. Kuchroo, and M. C. Nussenzweig. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20: 695-705. (Pubitemid 38757440)
39. Hochweller, K., and S. M. Anderton. 2005. Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo. Eur. J. Immunol. 35: 1086-1096. (Pubitemid 40542215)
40. Hochweller, K., C. H. Sweenie, and S. M. Anderton. 2006. Immunological tolerance using synthetic peptides: basic mechanisms and clinical application. Curr. Mol. Med. 6: 631-643. (Pubitemid 44377762)
41. Akashi, K., L. I. Richie, T. Miyamoto, W. H. Carr, and I. L. Weissman. 2000. B lymphopoiesis in the thymus. J. Immunol. 164: 5221-5226.
42. Seamons, A., A. Perchellet, and J. Goverman. 2006. Endogenous myelin basic protein is presented in the periphery by both dendritic cells and resting B cells with different functional consequences. J. Immunol. 177: 2097-2106. (Pubitemid 44200967)
43. + regulatory T cells and TGF-β? Gene Ther. 11: 1487-1496.
44. Townsend, S. E., and C. C. Goodnow. 1998. Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J. Exp. Med. 187: 1611-1621.
45. Lei, T. C., and D. W. Scott. 2005. Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood 105: 4865-4870.
46. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501. (Pubitemid 36278604)
47. Mauri, C., and M. R. Ehrenstein. 2008. The "short" history of regulatory B cells. Trends Immunol. 29: 34-40.